deltatrials
Completed OBSERVATIONAL NCT02548949

Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ (PMS)

KOREAN POST MARKETING SURVEILLANCE TO OBSERVE EFFECTIVENESS AND SAFETY OF PRISTIQ (REGISTERED) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

Sponsor: Pfizer

Conditions Major Depressive Disorder
Updated 28 times since 2017 Last updated: Jan 21, 2021 Started: Apr 25, 2016 Primary completion: Feb 12, 2020 Completion: Feb 12, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02548949, this observational or N/A phase trial focuses on Major Depressive Disorder and remains completed. Sponsored by Pfizer, it has been updated 28 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshot~Sep 2017 – ~Nov 2017 · 2 months · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Mar 2018 · 3 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Jun 2019 · 7 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~May 2020 · 3 months · monthly snapshot~May 2020 – ~Nov 2020 · 6 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Dec 2021 · 9 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

28 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2023 — Jul 2024 [monthly]

    Completed

  5. Dec 2022 — Jan 2023 [monthly]

    Completed

▶ Show 23 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Completed

  2. Mar 2021 — Dec 2021 [monthly]

    Completed

  3. Jan 2021 — Mar 2021 [monthly]

    Completed

  4. Nov 2020 — Jan 2021 [monthly]

    Completed

  5. May 2020 — Nov 2020 [monthly]

    Completed

    Status: Recruiting → Completed

  6. Feb 2020 — May 2020 [monthly]

    Recruiting

  7. Jan 2020 — Feb 2020 [monthly]

    Recruiting

  8. Dec 2019 — Jan 2020 [monthly]

    Recruiting

  9. Nov 2019 — Dec 2019 [monthly]

    Recruiting

  10. Oct 2019 — Nov 2019 [monthly]

    Recruiting

  11. Sep 2019 — Oct 2019 [monthly]

    Recruiting

  12. Jun 2019 — Sep 2019 [monthly]

    Recruiting

  13. Nov 2018 — Jun 2019 [monthly]

    Recruiting

  14. Jun 2018 — Nov 2018 [monthly]

    Recruiting

  15. May 2018 — Jun 2018 [monthly]

    Recruiting

  16. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  17. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

  18. Dec 2017 — Mar 2018 [monthly]

    Recruiting NA

  19. Nov 2017 — Dec 2017 [monthly]

    Recruiting NA

  20. Sep 2017 — Nov 2017 [monthly]

    Recruiting NA

  21. Aug 2017 — Sep 2017 [monthly]

    Recruiting NA

  22. Feb 2017 — Aug 2017 [monthly]

    Recruiting NA

  23. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anyang-si, South Korea , Bundang-gu, Seongnam-si, South Korea , Busan, South Korea , Cheongju-si, South Korea , Chungju, South Korea , Daegu, South Korea , Daejeon, South Korea , Gangwon-do, South Korea , Goyang-si, South Korea , Gwangju, South Korea and 4 more locations